Reshma Rangwala, EVP & Chief Medical Officer: Karyopharm Therapeutics KPTI Sell · Filed 23/04/24

Trade details

Type: Insider sale
Amount: $26,952.75
Shares · price: 6,655 sh · $4.05 a share
Held after: 158,230 sh
Stock: Karyopharm Therapeutics KPTI
Person: Reshma RangwalaEVP & Chief Medical Officer
Trade date: 23/04/20
Filed: 23/04/24
Days to filing: 4 days

Sold 4.0% of holdings

Share of holding sold: 4.0%

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/21~23/05/20

Reshma Rangwala's recent trades

Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$3,876
408 sh
$3,876
Filed 05/15
Traded 05/14
Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$4,014
449 sh
$4,014
Filed 04/22
Traded 04/21
Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$47.7K
5,066 sh
$47.7K
Filed 03/03
Traded 03/02
Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,623
408 sh
$2,623
Filed 25/09/16
Traded 25/09/15
Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,585
419 sh
$2,585
Filed 25/04/24
Traded 25/04/23

Reshma Rangwala, Chief Officer — sold $27K of Karyopharm Therapeutics KPTI · 4.0% of holdings · 10b5-1 plan | Whalegun